EFFECT OF SEXUAL BEHAVIOR ON PROSTATE-SPECIFIC ANTIGEN LEVELS IN MIDDLE-AGED MEN SCREENED FOR PROSTATE CANCER: RESULTS FROM THE PROBASE TRIAL

被引：0
|
作者：
Meissner, V. H. [1 ]
Hollerer, M. [1 ]
Kron, M. [2 ]
Schiele, S. [1 ]
Albers, P. [3 ]
Arsov, C. [3 ]
Kuczyk, M. [4 ]
Imkamp, F. [4 ]
Hohenfellner, M. [5 ]
Schutz, V [5 ]
Gschwend, J. E. [1 ]
Herkommer, K. [1 ]
机构：
[1] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Urol, Munich, Germany
[2] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany
[3] Heinrich Heine Univ, Univ Hosp Dusseldorf, Dept Urol, Dusseldorf, Germany
[4] Hannover Med Sch, Clin Urol & Urol Oncol, Hannover, Germany
[5] Ruprecht Karls Univ Heidelberg, Heidelberg Univ Hosp, Dept Urol, Heidelberg, Germany
来源：
JOURNAL OF SEXUAL MEDICINE | 2020年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
HP-4-5
引用
收藏
页码：S161 / S162
页数：2
相关论文
共 50 条
  • [21] Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels
    Richard M. Hoffman
    David L. Clanon
    Benjamin Littenberg
    Joseph J. Frank
    John C. Peirce
    Journal of General Internal Medicine, 2000, 15 : 739 - 748
  • [22] Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men
    Ilir Agalliu
    Noel S. Weiss
    Daniel W. Lin
    Janet L. Stanford
    Cancer Causes & Control, 2007, 18 : 931 - 937
  • [23] Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels
    Hoffman, RM
    Clanon, DL
    Littenberg, B
    Frank, JJ
    Peirce, JC
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (10) : 739 - 748
  • [24] The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels
    Cote, RJ
    Skinner, EC
    Salem, CE
    Mertes, SJ
    Stanczyk, FZ
    Henderson, BE
    Pike, MC
    Ross, RK
    BRITISH JOURNAL OF CANCER, 1998, 78 (03) : 413 - 418
  • [25] The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels
    RJ Cote
    EC Skinner
    CE Salem
    SJ Mertes
    FZ Stanczyk
    BE Henderson
    MC Pike
    RK Ross
    British Journal of Cancer, 1998, 78 : 413 - 418
  • [26] EFFECT OF LONG-TERM ORAL TESTOSTERONE UNDECANOATE TREATMENT ON PROSTATE VOLUME AND SERUM PROSTATE-SPECIFIC ANTIGEN CONCENTRATION IN EUGONADAL MIDDLE-AGED MEN
    HOLMANG, S
    MARIN, P
    LINDSTEDT, G
    HEDELIN, H
    PROSTATE, 1993, 23 (02): : 99 - 106
  • [27] Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer
    Beckett, ML
    Cazares, LH
    Vlahou, A
    Schellhammer, PF
    Wright, GL
    CLINICAL CANCER RESEARCH, 1999, 5 (12) : 4034 - 4040
  • [28] Prospective Randomized Evaluation of Risk-adapted Prostate-specific Antigen Screening in Young Men: The PROBASE Trial
    Arsov, Christian
    Becker, Nikolaus
    Hadaschik, Boris A.
    Hohenfellner, Markus
    Herkommer, Kathleen
    Gschwend, Ju Rgen E.
    Imkamp, Florian
    Kuczyk, Markus A.
    Antoch, Gerald
    Kristiansen, Glen
    Siener, Roswitha
    Semjonow, Axel
    Hamdy, Freddie C.
    Lilja, Hans
    Vicker, Andrew J.
    Schroeder, Fritz H.
    Albers, Peter
    EUROPEAN UROLOGY, 2013, 64 (06) : 873 - 875
  • [29] Serum prostate-specific antigen levels in Middle Eastern men with subclinical prostatitis
    Anim, J. T.
    Kehinde, E. O.
    Sheikh, M. A.
    Prasad, A.
    Mojiminiyi, O. A.
    Ali, Y.
    Al-Awadi, K. A.
    MEDICAL PRINCIPLES AND PRACTICE, 2007, 16 (01) : 53 - 58
  • [30] Prostate-specific antigen levels as a predictor of lethal prostate cancer
    Fall, Katja
    Garmo, Hans
    Andren, Ove
    Bill-Axelson, Anna
    Adolfsson, Jan
    Adami, Hans-Olov
    Johansson, Jan-Erik
    Holmberg, Lars
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07): : 526 - 532
12345